Navigation Links
Environmental risk assessment of pharmaceuticals inadequate
Date:10/18/2010

The strategies used to assess the environmental risks posed by pharmaceuticals are not enough to protect natural microbial communities, reveals a researcher from the University of Gothenburg (Sweden) who is calling for better environmental risk assessments.

"Above all, we need to include the combined effects of different drugs to reflect the situation in nature as it really is," says Sara Brosch from the Department of Plant and Environmental Sciences at the University of Gothenburg.

Modern medicine relies on pharmaceuticals for the treatment of practically everything, from headaches to cancer. The active substances in the drugs we take do not disappear into the body but are gradually secreted in urine and faeces. They then enter the sewerage system, and small amounts make it through the entire sewage treatment process.

Small quantities of pharmaceuticals are nowadays found in most aquatic environments, from groundwater to seawater. The highest concentrations are in the effluent from sewage treatment plants, often in the form of a cocktail of many different drugs. Once out in nature, these drug residues continue to affect living creatures. This applies particularly to antimicrobial agents such as antibiotics and antifungals, which are designed to kill microorganisms whether they are "bad" and cause infection, or "good" and serve important functions in nature.

"I saw effects on bacteria from the antibiotic chlortetracycline even at the concentrations shown in scientific publications to be present in the effluent from sewage treatment plants. Although chlortetracycline is no longer used in Sweden, many antibiotics from the same class are still in use."

In her research, Brosch has looked primarily at the combined effects of pharmaceuticals, as a cocktail of toxic substances will generally have a greater effect than the sum of its constituent parts. Her results show that although the levels of drugs normally seen in the environment are low, they are not without their risks.

"When five pharmaceuticals and personal care products (fluoxetine, propranolol, zinc pyritione, clotrimazole and triclosan) were mixed together at concentrations which did not have any significant effect individually, the mixture had an almost 30% effect on microalgae."

Brosch has also studied the high levels of antibiotics in effluents from pharmaceutical production in India. When microbial communities were exposed to this effluent, they rapidly developed increased tolerance to the antibiotic ciprofloxacin.


'/>"/>

Contact: Sara Brosch
sara.brosche@dpes.gu.se
46-704-035-816
University of Gothenburg
Source:Eurekalert

Related biology news :

1. Lack of large-scale experiments slows progress of environmental restoration
2. MU scientists go green with gold, distribute environmentally friendly nanoparticles
3. Growing a garden of future environmental leaders
4. Alternative to burning: environmentally sound disposal for wood chips
5. Childrens gardening programs grow environmental stewards
6. New center will focus environmental debate and produce solutions for action
7. 6 environmental research studies reveal critical health risks from plastic
8. Experts agree: Environmental standards needed for biofuels
9. Yale journal finds nanomaterials may have large environmental footprint
10. Childhood environmental health
11. North American environmental commission launches trinational vaquita conservation plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology: